113132-85-7 Usage
Chemical classification
Complex organic compound
Type of drug
Nonsteroidal anti-inflammatory drug (NSAID)
Therapeutic uses
Treatment of rheumatoid arthritis, osteoarthritis, and other inflammatory conditions
Mechanism of action
Inhibition of prostaglandin production, which are responsible for pain, inflammation, and fever
Molecular structure
Contains a mixture of oxygen, sulfur, nitrogen, and carbon atoms
Functional groups
Carboxylic acid and ester functional groups
Stereochemistry
[R-(R,R)]configuration
Chirality
The molecule has chiral centers, which means it can exist in different stereoisomeric forms
Ester group
1-(1,1-dimethylethyl) ester, which is a bulky group that can influence the molecule's biological activity and pharmacokinetic properties
Carboxylic acid groups
Two carboxylic acid groups at positions 3 and 10, which can form ionic interactions with biological targets and influence the compound's solubility and reactivity
Oxo group
Presence of a 12-oxo group, which can contribute to the molecule's reactivity and interaction with biological targets
Dithia and diaza groups
The molecule contains a 6,7-dithia and a 2,11-diaza group, which are part of its unique structure and contribute to its pharmacological properties
Molecular weight
Approximately 414.55 g/mol
These properties and contents provide a comprehensive overview of tiaprofenic acid, highlighting its chemical structure, functional groups, and therapeutic applications.
Check Digit Verification of cas no
The CAS Registry Mumber 113132-85-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,3,1,3 and 2 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 113132-85:
(8*1)+(7*1)+(6*3)+(5*1)+(4*3)+(3*2)+(2*8)+(1*5)=77
77 % 10 = 7
So 113132-85-7 is a valid CAS Registry Number.
113132-85-7Relevant articles and documents
Radiosynthesis and biological evaluation of L- and D-S-(3-[ 18F]fluoropropyl)homocysteine for tumor imaging using positron emission tomography
Bourdier, Thomas,Shepherd, Rachael,Berghofer, Paula,Jackson, Timothy,Fookes, Christopher J. R.,Denoyer, Delphine,Dorow, Donna S.,Greguric, Ivan,Gregoire, Marie-Claude,Hicks, Rodney J.,Katsifis, Andrew
scheme or table, p. 1860 - 1870 (2011/05/19)
Interest in radiolabeled amino acids for metabolic imaging of cancer and limitations with [11C]methionine has prompted the development of a new 18F-labeled methionine derivative S-(3-[18F] fluoropropyl)homocysteine ([
